Developer docs
API playgroundTry for free, no card

Search company profiles

BioD

Full company profile

uuid002pbvi

Namestring
BioD
Websiteurl
biodlogics.com
Company typeenum
Private
Founded yearint
2005
Descriptiontext

BioD, LLC is a privately held biotechnology company founded in 2005 and headquartered in Cordova, Tennessee, United States. The firm describes itself as vertically integrated, which implies it operates across multiple stages of the biotechnology value chain internally rather than outsourcing core functions, though the specific therapeutic areas, modalities, or product portfolio are not detailed in the available source materials. The company maintains a headcount of 11-50 employees, a size band consistent with a small-cap specialty biotech rather than a fully scaled commercial operation, and operates a website at biodlogics.com that signals a likely biologics orientation.

The available input data contains no details on BioD's product portfolio, technology platforms, patents and trademarks, regulatory certifications, distribution channels, marketing channels, pricing, customers, management team, funding history, recent strategic actions, or geographic footprint. As a privately held company with no public ticker and no documented funding rounds, BioD's revenue model, go-to-market mechanics, capital structure, and commercial status cannot be characterized from these sources. Investors evaluating the firm would require direct management dialogue, FDA/regulatory filings where applicable, or proprietary data sources to confirm its therapeutic focus, technology stack, IP position, and competitive standing.

The only market-context reference in the source material is a USD 32.44 billion 2025 global bar soap market figure (projected to USD 48.14 billion by 2034), which the source itself flags as only potentially relevant if BioD operates in natural or eco-friendly personal care — a positioning inconsistent with the firm's stated biotechnology identity. This market reference should be treated as low-relevance context rather than a directly applicable sizing for BioD's addressable market.

Short descriptiontext

BioD, LLC is a privately held, vertically integrated biotechnology company headquartered in Cordova, United States. Founded in 2005, the firm operates with 11-50 employees, though specific therapeutic focus, products, and technology platforms are not detailed in available sources.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCordova, United States
HQ citystring
Cordova
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biologics manufacturing, biotechnology products, biopharmaceutical development, regenerative biologics, life sciences solutions
Industry1 code
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Biologics Manufacturing
Social media profiles1 record
Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

BioD, LLC is a vertically integrated biotechnology company. The firm operates across the full value chain of biologic product development, manufacturing, and commercialization, though specific product offerings, therapeutic areas, and customer segments are not detailed in the available source material.

Differentiator
Functional benefit
Problem solved
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Peers10 records
TypeEmerging player
Description

CollPlant develops recombinant human collagen-based regenerative products for orthopedics and wound care, an emerging tissue-biologics competitor that targets similar clinical use cases to BioD's allografts.

TypeDirect peer
Description

Osiris developed placental and adipose tissue allografts (Grafix, OvationOS) for wound healing and orthopedic applications, making it a near-direct comparand to BioD's amniotic tissue platform.

TypeDirect peer
Description

Anika Therapeutics is a regenerative medicine and orthobiologics company (hyaluronic acid-based HA, surgical tissue products) competing with BioD in the surgical reconstruction and sports medicine adjacencies.

TypeDirect peer
Description

Organogenesis is a regenerative medicine company commercializing wound care and surgical biologics (Apligraf, Dermagraft, PuraPly), competing head-to-head with BioD in tissue-based advanced wound care and surgical reconstruction.

TypeBroad incumbent
Description

Smith & Nephew offers a broad advanced wound management and orthobiologics portfolio (including skin substitutes and tissue regeneration products) that overlaps with BioD's clinical use cases.

TypeDirect peer
Description

MiMedx develops and markets placental tissue allografts (EpiFix, AmnioFix) for wound care and surgical applications, the closest direct competitor to BioD's amniotic membrane-based product line.

TypeDirect peer
Description

AlloSource is a nonprofit tissue manufacturer providing allografts for wound care, sports medicine, and surgical reconstruction, competing directly with BioD across amniotic and connective tissue allograft categories.

TypeBroad incumbent
Description

Stryker is a diversified medtech incumbent with orthobiologics, regenerative, and surgical reconstruction product lines that compete broadly with BioD across hospital and ambulatory surgical channels.

TypeEmerging player
Description

Vericel commercializes advanced cell therapies and biologic products for severe burn and cartilage repair, representing an adjacent tissue/biologic competitor serving overlapping surgical and wound care end markets.

TypeBroad incumbent
Description

Integra LifeSciences is a global surgical reconstruction and neurosurgery medtech leader whose product catalog now features BioD's amniotic tissue technology, making it both a commercial partner and a broad incumbent comparator.

Market position
Strengths2 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BioD

Biologics Manufacturingbiodlogics.com

BioD, LLC is a privately held, vertically integrated biotechnology company headquartered in Cordova, United States. Founded in 2005, the firm operates with 11-50 employees, though specific therapeutic focus, products, and technology platforms are not detailed in available sources.

What BioD does

BioD, LLC is a privately held biotechnology company founded in 2005 and headquartered in Cordova, Tennessee, United States. The firm describes itself as vertically integrated, which implies it operates across multiple stages of the biotechnology value chain internally rather than outsourcing core functions, though the specific therapeutic areas, modalities, or product portfolio are not detailed in the available source materials. The company maintains a headcount of 11-50 employees, a size band consistent with a small-cap specialty biotech rather than a fully scaled commercial operation, and operates a website at biodlogics.com that signals a likely biologics orientation.

The available input data contains no details on BioD's product portfolio, technology platforms, patents and trademarks, regulatory certifications, distribution channels, marketing channels, pricing, customers, management team, funding history, recent strategic actions, or geographic footprint. As a privately held company with no public ticker and no documented funding rounds, BioD's revenue model, go-to-market mechanics, capital structure, and commercial status cannot be characterized from these sources. Investors evaluating the firm would require direct management dialogue, FDA/regulatory filings where applicable, or proprietary data sources to confirm its therapeutic focus, technology stack, IP position, and competitive standing.

The only market-context reference in the source material is a USD 32.44 billion 2025 global bar soap market figure (projected to USD 48.14 billion by 2034), which the source itself flags as only potentially relevant if BioD operates in natural or eco-friendly personal care — a positioning inconsistent with the firm's stated biotechnology identity. This market reference should be treated as low-relevance context rather than a directly applicable sizing for BioD's addressable market.

BioD firmographics

Firmographics
Name
BioD
Website
https://biodlogics.com
Company type
Private
Founded year
2005
Headcount range
11–50 employees
Short description
BioD, LLC is a privately held, vertically integrated biotechnology company headquartered in Cordova, United States. Founded in 2005, the firm operates with 11-50 employees, though specific therapeutic focus, products, and technology platforms are not detailed in available sources.
Ownership category
akta.pro rank

BioD industry classification

Industry
Product category
Biologics Manufacturing
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAGABAC
Biologics (mAbs/Recombinant Proteins) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Biologics manufacturing
  • Biotechnology products
  • Biopharmaceutical development
  • Regenerative biologics
  • Life sciences solutions

Where BioD is headquartered

Location

Headquarters

HQ city
Cordova
HQ country
United States
HQ region
North America

Markets served

BioD business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

BioD product offering

Product offering

Core offering

BioD, LLC is a vertically integrated biotechnology company. The firm operates across the full value chain of biologic product development, manufacturing, and commercialization, though specific product offerings, therapeutic areas, and customer segments are not detailed in the available source material.

Differentiator

Problem solved

Functional benefit

Companies that use BioD

Customer profile

Ideal customer profiles1 record

BioD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

BioD partnerships and signals

Strategic signal

Scale indicators1 record

BioD competitors and assessment

Company assessment

Emerging players

  • CollPlant Biotechnologies: CollPlant develops recombinant human collagen-based regenerative products for orthopedics and wound care, an emerging tissue-biologics competitor that targets similar clinical use cases to BioD's allografts.
  • Vericel: Vericel commercializes advanced cell therapies and biologic products for severe burn and cartilage repair, representing an adjacent tissue/biologic competitor serving overlapping surgical and wound care end markets.

Direct peers

  • Osiris Therapeutics (a Smith & Nephew company): Osiris developed placental and adipose tissue allografts (Grafix, OvationOS) for wound healing and orthopedic applications, making it a near-direct comparand to BioD's amniotic tissue platform.
  • Anika Therapeutics: Anika Therapeutics is a regenerative medicine and orthobiologics company (hyaluronic acid-based HA, surgical tissue products) competing with BioD in the surgical reconstruction and sports medicine adjacencies.
  • Organogenesis: Organogenesis is a regenerative medicine company commercializing wound care and surgical biologics (Apligraf, Dermagraft, PuraPly), competing head-to-head with BioD in tissue-based advanced wound care and surgical reconstruction.
  • MiMedx: MiMedx develops and markets placental tissue allografts (EpiFix, AmnioFix) for wound care and surgical applications, the closest direct competitor to BioD's amniotic membrane-based product line.
  • AlloSource: AlloSource is a nonprofit tissue manufacturer providing allografts for wound care, sports medicine, and surgical reconstruction, competing directly with BioD across amniotic and connective tissue allograft categories.

Broad incumbents

  • Smith & Nephew: Smith & Nephew offers a broad advanced wound management and orthobiologics portfolio (including skin substitutes and tissue regeneration products) that overlaps with BioD's clinical use cases.
  • Stryker: Stryker is a diversified medtech incumbent with orthobiologics, regenerative, and surgical reconstruction product lines that compete broadly with BioD across hospital and ambulatory surgical channels.
  • Integra LifeSciences: Integra LifeSciences is a global surgical reconstruction and neurosurgery medtech leader whose product catalog now features BioD's amniotic tissue technology, making it both a commercial partner and a broad incumbent comparator.

Market position

Strengths2 records

Weaknesses4 records

Key risks4 records

Key highlights4 records

Customer concentration

BioD social profiles

Digital presence

BioD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BioD leadership team

Management profile

Number of profiles

BioD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BioD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioD

What does BioD do?

BioD, LLC is a vertically integrated biotechnology company. The firm operates across the full value chain of biologic product development, manufacturing, and commercialization, though specific product offerings, therapeutic areas, and customer segments are not detailed in the available source material.

When was BioD founded?

BioD was founded in 2005. It employs 11 to 50 people.

Where is BioD based?

BioD is headquartered in Cordova, United States, in the North America region.

Who are BioD's main competitors?

Emerging players on record are CollPlant Biotechnologies and Vericel. Direct peers are Osiris Therapeutics (a Smith & Nephew company), Anika Therapeutics, Organogenesis, MiMedx and AlloSource. Broad incumbents are Smith & Nephew, Stryker and Integra LifeSciences.

Does BioD have an API?

No public API is recorded for BioD.

What industry is BioD in?

BioD's product category is Biologics Manufacturing. Its primary akta.pro industry code is HLAGABAC, Biologics (mAbs/Recombinant Proteins) CDMO. Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals